O-acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant
- PMID: 6206564
- DOI: 10.1126/science.6206564
O-acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant
Abstract
Monoclonal antibody Mab D1.1 recognizes on human melanoma cells a ganglioside antigen characterized by an alkali-labile O-acetylated sialic acid residue. Immunochemical analysis showed that this molecule is an O-acetylated product of the neuroectoderm-associated disialoganglioside GD3. Controlled chemical O-acetylation of purified GD3 resulted in the generation of this same epitope. Lysates of human melanoma cells were found to contain O-acetyltransferase activity capable of generating the antigenic epitope recognized by Mab D1.1. Thus, the addition of a single O-acetyl group to a common cell surface-associated ganglioside can create a potentially tumor-specific antigen.
Similar articles
-
Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.J Biol Chem. 1992 Aug 15;267(23):16200-11. J Biol Chem. 1992. PMID: 1644805
-
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.Cancer Res. 1989 Jul 15;49(14):3891-7. Cancer Res. 1989. PMID: 2472199
-
A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside.J Biol Chem. 1984 Jun 25;259(12):7453-9. J Biol Chem. 1984. PMID: 6203895
-
Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.Cancer Treat Res. 1991;54:137-51. doi: 10.1007/978-1-4615-3938-4_8. Cancer Treat Res. 1991. PMID: 1673856 Review.
-
O-acetylated Gangliosides as Targets for Cancer Immunotherapy.Cells. 2020 Mar 17;9(3):741. doi: 10.3390/cells9030741. Cells. 2020. PMID: 32192217 Free PMC article. Review.
Cited by
-
Monoclonal antibody 18B8 detects gangliosides associated with neuronal differentiation and synapse formation.Proc Natl Acad Sci U S A. 1985 Jun;82(12):4008-12. doi: 10.1073/pnas.82.12.4008. Proc Natl Acad Sci U S A. 1985. PMID: 3858858 Free PMC article.
-
Complementary immunolocalization patterns of cell wall hydroxyproline-rich glycoproteins studied with the use of antibodies directed against different carbohydrate epitopes.Plant Physiol. 1993 Jul;102(3):891-901. doi: 10.1104/pp.102.3.891. Plant Physiol. 1993. PMID: 7506427 Free PMC article.
-
Perspectives on the significance of altered glycosylation of glycoproteins in cancer.Glycoconj J. 1997 Aug;14(5):569-76. doi: 10.1023/a:1018580324971. Glycoconj J. 1997. PMID: 9298689 Review. No abstract available.
-
Mechanistic insights into the acetyl-CoA recognition by SLC33A1.Cell Discov. 2025 Apr 10;11(1):36. doi: 10.1038/s41421-025-00793-1. Cell Discov. 2025. PMID: 40204708 Free PMC article. No abstract available.
-
Histochemical procedures for the simultaneous visualization of neutral sugars and either sialic acid and its side chain O-acyl variants or O-sulphate ester. I. Methods based upon the selective periodate oxidation of sialic acids.Histochem J. 1987 May;19(5):249-56. doi: 10.1007/BF01675683. Histochem J. 1987. PMID: 3038793
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical